Delivery Order SPE2DB22D1017-SPE2DB25FG2CF

Award Date 5/8/25
Potential Completion Date 5/9/25
Potential Value $1.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,990.26, is for the delivery of 4,567,985,363 units of Tamsulosin HCl 0.4 mg capsules. The contract is a firm fixed-price delivery order, with an ultimate completion date of April 22, 2025. AmerisourceBergen Drug Corp is the prime contractor, and there is no set-aside designation, indicating...
This is a firm-fixed price delivery order contract worth $9,139.98 awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide 1,000 units of Tamsulosin HCl 0.4 mg capsules. The contract has an ultimate completion date of March 6, 2024. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999 through November 2026, which serves as the primary vehicle for providing...
This is a $1,912.62 delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The order is for 4,564,591,709 units of the generic drug Tamsulosin HCL 0.4 mg capsules, to be delivered by May 14, 2024. The contract is a firm fixed-price delivery order with no set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This is a Delivery Order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,715.49 firm fixed-price contract is for the delivery of 4,564,465,528 units of Tamsulosin HCl 0.4 mg capsules. The award is not designated as a set-aside contract. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division, which serves as a primary vehicle for...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the procurement of 1,000 units of the drug Tamsulosin Hydrochloride 0.4 mg capsules. The contract has a firm fixed price of $1,791.90 and a period of performance through March 26, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical to...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,778.86 Firm Fixed Price contract is for the supply of 4,567,152,479 units of Tamsulosin HCL 0.4 mg capsules. The contract has a completion date of February 5, 2025 and was awarded on February 4, 2025. This order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 1,000 units of Tamsulosin HCL 0.4 mg capsules. The delivery order has a firm fixed price of $2,520.38 and a period of performance through March 31, 2025. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a $1,868.96 firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 1,000 units of the drug Tamsulosin HCL 0.4 mg capsules. The contract has an ultimate completion date of January 22, 2025. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999, which serves as the primary vehicle for...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Tamsulosin HCL 0.4 mg capsules, with a ceiling value of $1,264.83 and a period of performance through April 11, 2025. The contract is a firm fixed-price, non-set-aside award, indicating open competition. Amerisourcebergen Drug Corp is the prime contractor and is responsible for...
This is a $1,243.12 firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4,567,903,368 capsules of the generic drug Tamsulosin HCL 0.4 mg. The delivery order has an ultimate completion date of April 15, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running...
  • SPE2DB22D1017
    Indefinite Delivery Contract
  • SPE2DB22D1017-SPE2DB25FG2CF
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 1,000 units of the prescription medication Tamsulosin HCL 0.4 mg capsule. The delivery order, valued at $1,615.16, is a firm fixed-price contract with a period of performance through May 9, 2025. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This delivery order is not set aside and represents an open competition award. The contract supports the procurement of pharmaceutical products for federal agencies, including the Defense Health Agency and U.S. Coast Guard.

Generated 8/10/25, 1:00 AM